TRAIL R3 (Extracellular Domain – 2) Blocking Peptide

TRAIL R3 (Extracellular Domain – 2) Blocking Peptide

Product No.: D265

[product_table name="All Top" skus="D265"]

- -
- -
Target
TNF-Related Apoptosis-Inducing Ligand Receptor 3
Product Type
Blocking Peptide
Alternate Names
TRID, TNFRSF10C, CD263, DCR1, LIT, MGC149501, MGC149502

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 111 to 123 of Human DcR1 protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
TNF-related apoptosis-inducing ligand receptor 3 (TRAIL R3) is an antagonist decoy receptor1 that can inhibit TRAIL-induced apoptosis.2 TRAIL R3 is a plasma membrane-bound protein capable of high affinity interaction with the TRAIL ligand.3

Antigen Details

References & Citations

1. Fornace AJ Jr. et al. (1999) Oncogene 18: 4153 2. Büchler MW et al. (2001) Anticancer Res. 21: 3153 3. Smith CA et al. (1997) J Exp Med. 186: 1165
Products are for research use only. Not for use in diagnostic or therapeutic procedures.